Vaccination of the solid organ transplant recipient

Transplantation Reviews

Volumn 22, Issue 4, 2008, Pages 274-284

  Sester, Martina ^a   Gärtner, Barbara C ^a   Girndt, Matthias ^a   Sester, Urban ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CHICKENPOX VACCINE; CHOLERA VACCINE; CORTICOSTEROID; CYCLOSPORIN A; DACLIZUMAB; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; LIVE VACCINE; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; ORAL POLIOMYELITIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RITUXIMAB; STEROID; TACROLIMUS; TETANUS TOXOID; THYMOCYTE ANTIBODY; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE;

ABSENCE OF SIDE EFFECTS; ACTIVE IMMUNIZATION; ANTIBODY TITER; ARTICLE; CHOLERA; CONDYLOMA ACUMINATUM; DIPHTHERIA; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; GRAFT REJECTION; HAEMOPHILUS INFLUENZAE; HEPATITIS A; HEPATITIS B; HERPES ZOSTER; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA; LOW DRUG DOSE; MENINGOCOCCOSIS; NONHUMAN; ORGAN TRANSPLANTATION; POLIOMYELITIS; SINGLE DRUG DOSE; SKIN ATROPHY; STREPTOCOCCUS INFECTION; TETANUS; VACCINATION;

EID: 51949098141     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trre.2008.07.001     Document Type: Article

References (82)

1. Fishman J.A. Infection in solid-organ transplant recipients. N Engl J Med 357 (2007) 2601-2614
2. Boggild A.K., Sano M., Humar A., Salit I., Gilman M., and Kain K.C. Travel patterns and risk behavior in solid organ transplant recipients. J Travel Med 11 (2004) 37-43
3. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 4 Suppl 10 (2004) 160-163
4. Huzly D., Neifer S., Reinke P., et al. Routine immunizations in adult renal transplant recipients. Transplantation 63 (1997) 839-845
5. Scharpé J., Evenepoel P., Maes B., et al. Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant (2007)
6. Girndt M., Pietsch M., and Köhler H. Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure. Am J Kidney Dis 26 (1995) 454-460
7. Campbell A.L., and Herold B.C. Immunization of pediatric solid-organ transplantation candidates: immunizations in transplant candidates. Pediatr Transplant 9 (2005) 652-661
8. Casswall T.H., and Fischler B. Vaccination of the immunocompromised child. Expert Rev Vaccines 4 (2005) 725-738
9. Verma A., and Wade J.J. Immunization issues before and after solid organ transplantation in children. Pediatr Transplant 10 (2006) 536-548
10. Burroughs M., and Moscona A. Immunization of pediatric solid organ transplant candidates and recipients. Clin Infect Dis 30 (2000) 857-869
11. Halloran P.F. Immunosuppressive drugs for kidney transplantation. N Engl J Med 351 (2004) 2715-2729
12. Blumberg E.A., Brozena S.C., Stutman P., Wood D., Phan H.M., and Musher D.M. Immunogenicity of pneumococcal vaccine in heart transplant recipients. Clin Infect Dis 32 (2001) 307-310
13. Avery R.K. Recipient screening prior to solid-organ transplantation. Clin Infect Dis 35 (2002) 1513-1519
14. O'Sullivan J., Dark J.H., and Gould K. Haemophilus influenzae immunisation and timing of cardiac transplantation. Lancet 342 (1993) 859
15. Pedrazzi C., Ghio L., Balloni A., et al. Duration of immunity to diphtheria and tetanus in young kidney transplant patients. Pediatr Transplant 3 (1999) 109-114
16. Amber I.J., Gilbert E.M., Schiffman G., and Jacobson J.A. Increased risk of pneumococcal infections in cardiac transplant recipients. Transplantation 49 (1990) 122-125
17. Blumberg E.A., Fitzpatrick J., Stutman P.C., Hayden F.G., and Brozena S.C. Safety of influenza vaccine in heart transplant recipients. J Heart Lung Transplant 17 (1998) 1075-1080
18. Kobashigawa J.A., Warner-Stevenson L., Johnson B.L., et al. Influenza vaccine does not cause rejection after cardiac transplantation. Transplant Proc 25 (1993) 2738-2739
19. Kimball P., Verbeke S., Flattery M., Rhodes C., and Tolman D. Influenza vaccination does not promote cellular or humoral activation among heart transplant recipients. Transplantation 69 (2000) 2449-2451
20. Grekas D., Alivanis P., Kiriazopoulou V., et al. Influenza vaccination on renal transplant patients is safe and serologically effective. Int J Clin Pharmacol Ther Toxicol 31 (1993) 553-556
21. Burbach G., Bienzle U., Stark K., et al. Influenza vaccination in liver transplant recipients. Transplantation 67 (1999) 753-755
22. White-Williams C., Brown R., Kirklin J., et al. Improving clinical practice: should we give influenza vaccinations to heart transplant patients?. J Heart Lung Transplant 25 (2006) 320-323
23. Magnani G., Falchetti E., Pollini G., et al. Safety and efficacy of two types of influenza vaccination in heart transplant recipients: a prospective randomised controlled study. J Heart Lung Transplant 24 (2005) 588-592
24. Avery R.K., and Ljungman P. Prophylactic measures in the solid-organ recipient before transplantation. Clin Infect Dis 33 Suppl 1 (2001) S15-S21
25. Rubin R.H. Influenza and the transplant recipient. Transpl Infect Dis 4 (2002) 175-176
26. Vilchez R.A., McCurry K., Dauber J., et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2 (2002) 287-291
27. Keane W.R., Helderman J.H., Luby J., Gailiunas P., Hull A.R., and Kokko J.P. Epidemic renal transplant rejection associated with influenza A victoria. Proc Clin Dial Transplant Forum 8 (1978) 232-236
28. Duchini A., Hendry R.M., Redfield D.C., and Pockros P.J. Influenza infection in patients before and after liver transplantation. Liver Transpl 6 (2000) 531-542
29. Hayden F.G. Prevention and treatment of influenza in immunocompromised patients. Am J Med 102 (1997) 55-60 [discussion 75-56]
30. Breinig T., Sester M., Sester U., and Meyerhans A. Antigen-specific T cell responses: determination of their frequencies, homing properties, and effector functions in human whole blood. Methods 38 (2006) 77-83
31. Robinson H.L., and Amara R.R. T cell vaccines for microbial infections. Nat Med 11 (2005) S25-S32
32. Gershon A.A. Immunizations for pediatric transplant patients. Kidney Int Suppl 43 (1993) S87-S90
33. Gupta R.K., and Siber G.R. Adjuvants for human vaccines-current status, problems and future prospects. Vaccine 13 (1995) 1263-1276
34. Nohria A., and Rubin R.H. Cytokines as potential vaccine adjuvants. Biotherapy 7 (1994) 261-269
35. Bienzle U., Gunther M., Neuhaus R., et al. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease. Hepatology 38 (2003) 811-819
36. Belshe R.B., Newman F.K., Cannon J., et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 351 (2004) 2286-2294
37. Micozkadioglu H., Zumrutdal A., Torun D., Sezer S., Ozdemir F.N., and Haberal M. Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients. Ren Fail 29 (2007) 285-288
38. Charest A.F., McDougall J., and Goldstein M.B. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am J Kidney Dis 36 (2000) 976-982
39. Manuel O., Humar A., Chen M.H., et al. Immunogenicity and safety of an intradermal boosting strategy for vaccination against influenza in lung transplant recipients. Am J Transplant 7 (2007) 2567-2572
40. Choy B.Y., Peiris J.S., Chan T.M., Lo S.K., Lui S.L., and Lai K.N. Immunogenicity of intradermal hepatitis B vaccination in renal transplant recipients. Am J Transplant 2 (2002) 965-969
41. Wendt C.H. Community respiratory viruses: organ transplant recipients. Am J Med 102 (1997) 31-36 [discussion 42-33]
42. Weinstock D.M., Gubareva L.V., and Zuccotti G. Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. N Engl J Med 348 (2003) 867-868
43. Admon D., Engelhard D., Strauss N., Goldman N., and Zakay-Rones Z. Antibody response to influenza immunization in patients after heart transplantation. Vaccine 15 (1997) 1518-1522
44. Cavdar C., Sayan M., Sifil A., et al. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients. Scand J Urol Nephrol 37 (2003) 71-76
45. Enke B.U., Bokenkamp A., Offner G., Bartmann P., and Brodehl J. Response to diphtheria and tetanus booster vaccination in pediatric renal transplant recipients. Transplantation 64 (1997) 237-241
46. Kretsinger K., Broder K.R., Cortese M.M., et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 55 (2006) 1-37
47. Kumar D., Humar A., Plevneshi A., et al. Invasive pneumococcal disease in solid organ transplant recipients-10-year prospective population surveillance. Am J Transplant 7 (2007) 1209-1214
48. Dengler T.J., Strnad N., Buhring I., et al. Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. Transplantation 66 (1998) 1340-1347
49. Kazancioglu R., Sever M.S., Yuksel-Onel D., et al. Immunization of renal transplant recipients with pneumococcal polysaccharide vaccine. Clin Transplant 14 (2000) 61-65
50. Kumar D., Rotstein C., Miyata G., Arlen D., and Humar A. Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients. J Infect Dis 187 (2003) 1639-1645
51. Kumar D., Welsh B., Siegal D., Chen M.H., and Humar A. Immunogenicity of pneumococcal vaccine in renal transplant recipients-three year follow-up of a randomized trial. Am J Transplant 7 (2007) 633-638
52. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 46 (1997) 1-24
53. Bilukha O.O., and Rosenstein N. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 54 (2005) 1-21
54. Farley M.M., Stephens D.S., Brachman Jr. P.S., Harvey R.C., Smith J.D., and Wenger J.D. Invasive Haemophilus influenzae disease in adults. A prospective, population-based surveillance. CDC Meningitis Surveillance Group. Ann Intern Med 116 (1992) 806-812
55. Sever M.S., Yildiz A., Eraksoy H., et al. Immune response to Haemophilus influenzae type B vaccination in renal transplant recipients with well-functioning allografts. Nephron 81 (1999) 55-59
56. Stark K., Gunther M., Neuhaus R., et al. Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. J Infect Dis 180 (1999) 2014-2017
57. Arslan M., Wiesner R.H., Poterucha J.J., Gross J.B., and Zein N.N. Hepatitis A antibodies in liver transplant recipients: evidence for loss of immunity posttransplantation. Liver Transpl 6 (2000) 191-195
58. Gunther M., Stark K., Neuhaus R., Reinke P., Schroder K., and Bienzle U. Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation 71 (2001) 477-479
59. Rosenau J., Hooman N., Hadem J., et al. Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation. Liver Transpl 13 (2007) 367-373
60. Loinaz C., de Juanes J.R., Gonzalez E.M., et al. Hepatitis B vaccination results in 140 liver transplant recipients. Hepato-gastroenterology 44 (1997) 235-238
61. Gunther M., Neuhaus R., Bauer T., Jilg W., Holtz J.A., and Bienzle U. Immunization with an adjuvant hepatitis B vaccine in liver transplant recipients: antibody decline and booster vaccination with conventional vaccine. Liver Transpl 12 (2006) 316-319
62. Furth S.L., and Fivush B.A. Varicella vaccination in pediatric kidney transplant candidates. Pediatr Transplant 6 (2002) 97-100
63. Weinberg A., Horslen S.P., Kaufman S.S., et al. Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. Am J Transplant 6 (2006) 565-568
64. Khan S., Erlichman J., and Rand E.B. Live virus immunization after orthotopic liver transplantation. Pediatr Transplant 10 (2006) 78-82
65. Kraft J.N., and Shaw J.C. Varicella infection caused by Oka strain vaccine in a heart transplant recipient. Arch Dermatol 142 (2006) 943-945
66. Levitsky J., Te H.S., Faust T.W., and Cohen S.M. Varicella infection following varicella vaccination in a liver transplant recipient. Am J Transplant 2 (2002) 880-882
67. Other herpesviruses: HHV-6, HHV-7, HHV-8, HSV-1 and-2, VZV. Am J Transplant 4 Suppl 10 (2004) 66-71
68. Oxman M.N., Levin M.J., Johnson G.R., et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352 (2005) 2271-2284
69. Weinstock H., Berman S., and Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 36 (2004) 6-10
70. Human papillomavirus infection. Am J Transplant 4 Suppl 10 (2004) 95-100
71. Stanley M., Lowy D.R., and Frazer I. Chapter 12: prophylactic HPV vaccines: underlying mechanisms. Vaccine 24 Suppl 3 (2006) S106-S113
72. Koutsky L.A., and Harper D.M. Chapter 13: current findings from prophylactic HPV vaccine trials. Vaccine 24 Suppl 3 (2006) S114-S121
73. Olsson S.E., Villa L.L., Costa R.L., et al. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine. Vaccine 25 (2007) 4931-4939
74. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., and Unger E.R. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56 (2007) 1-24
75. Kotton C.N., Ryan E.T., and Fishman J.A. Prevention of infection in adult travelers after solid organ transplantation. Am J Transplant 5 (2005) 8-14
76. Dengler T.J., Zimmermann R., Meyer J., Sack F.U., Girgsdies O., and Kubler W.E. Vaccination against tick-borne encephalitis under therapeutic immunosuppression. Reduced efficacy in heart transplant recipients. Vaccine 17 (1999) 867-874
77. Cetron M.S., Marfin A.A., Julian K.G., et al. Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm Rep 51 (2002) 1-11 quiz CE11-14
78. Geiger R., Fink F.M., Solder B., Sailer M., and Enders G. Persistent rubella infection after erroneous vaccination in an immunocompromised patient with acute lymphoblastic leukemia in remission. J Med Virol 47 (1995) 442-444
79. Chitsike I., and van Furth R. Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in child with HIV infection in Zimbabwe: case report. BMJ 318 (1999) 841-843
80. Stewart S., Murray S.B., and Skull S.A. Evaluation of health-care worker vaccination in a tertiary Australian hospital. Intern Med J 32 (2002) 585-592
81. Halpern S.D., Asch D.A., Shaked A., Stock P., and Blumberg E.A. Inadequate hepatitis B vaccination and post-exposure evaluation among transplant surgeons: prevalence, correlates, and implications. Ann Surg 244 (2006) 305-309
82. Kumar D., and Humar A. Pandemic influenza and its implications for transplantation. Am J Transplant 6 (2006) 1512-1517